Er Therapeutics Stock Market Value
| PNGM Stock | USD 0.0001 0.00 0.00% |
| Symbol | PNGM |
Is Diversified Metals & Mining space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Er Therapeutics. If investors know PNGM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Er Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.95) |
The market value of Er Therapeutics is measured differently than its book value, which is the value of PNGM that is recorded on the company's balance sheet. Investors also form their own opinion of Er Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Er Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Er Therapeutics' market value can be influenced by many factors that don't directly affect Er Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Er Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Er Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Er Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Er Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Er Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Er Therapeutics.
| 01/04/2023 |
| 12/24/2024 |
If you would invest 0.00 in Er Therapeutics on January 4, 2023 and sell it all today you would earn a total of 0.00 from holding Er Therapeutics or generate 0.0% return on investment in Er Therapeutics over 720 days. Er Therapeutics is related to or competes with Vale SA, Glencore PLC, Piedmont Lithium, and Sigma Lithium. Pengram Corporation, an exploration stage mining company, engages in the acquisition, exploration, and development of na... More
Er Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Er Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Er Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Er Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Er Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Er Therapeutics' standard deviation. In reality, there are many statistical measures that can use Er Therapeutics historical prices to predict the future Er Therapeutics' volatility.Er Therapeutics Backtested Returns
We have found three technical indicators for Er Therapeutics, which you can use to evaluate the volatility of the firm. The firm owns a Beta (Systematic Risk) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Er Therapeutics are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Er Therapeutics has perfect predictability. Overlapping area represents the amount of predictability between Er Therapeutics time series from 4th of January 2023 to 30th of December 2023 and 30th of December 2023 to 24th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Er Therapeutics price movement. The serial correlation of 1.0 indicates that 100.0% of current Er Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Er Therapeutics lagged returns against current returns
Autocorrelation, which is Er Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Er Therapeutics' stock expected returns. We can calculate the autocorrelation of Er Therapeutics returns to help us make a trade decision. For example, suppose you find that Er Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Er Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Er Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Er Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Er Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Er Therapeutics Lagged Returns
When evaluating Er Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Er Therapeutics stock have on its future price. Er Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Er Therapeutics autocorrelation shows the relationship between Er Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Er Therapeutics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Er Therapeutics Correlation, Er Therapeutics Volatility and Er Therapeutics Alpha and Beta module to complement your research on Er Therapeutics. To learn how to invest in PNGM Stock, please use our How to Invest in Er Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Er Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.